IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2020 Holdings

Filed 2020-05-15 | 12 holdings | $204.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$203.4M643,00099.7%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$136.5K13,525,0000.1%
Alkermes PLC(ALKS)SHSG01767105$103.7K7,193,0000.1%
Allergan PLCSHSG0177J108$82.8K467,5000.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$76.3K765,0000.0%
Abbvie Inc(ABBV)COM00287Y109$76.0K1,0000.0%
Innoviva Inc(INVA)COM45781M101$73.4K6,242,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$72.7K1,155,0000.0%
Mersana Therapeutics IncCOM59045L106$21.9K3,750,0000.0%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$12.1K135,0000.0%
Regulus Therapeutics IncCOM NEW75915K200$8531,851,8510.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$761,0000.0%